CYLYSE Trademark
CYLYSE is a USPTO trademark filed by Sysmex Corporation. Status: Registered.
Prosecution Summary
Trademark Summary
CYLYSE is a standard character mark owned by Sysmex Corporation, a Japanese corporation based in Kobe, Hyogo, covering chemical reagents, diagnostic reagents, in vitro diagnostic preparations and reagents, and hemolytic agents for medical or veterinary purposes in International Class 005, with additional domestic classes 006, 018, 044, 046, 051, and 052. The mark is registered on the Principal Register as of September 26, 2023, under Registration Number 7176194, with priority claimed from Japanese Registration 5865356 dated July 8, 2016. It claims a prior U.S. registration (5139473) and was filed on a foreign registration basis after deleting the intent-to-use basis.
Recent Activity
Filed January 27, 2023, the application was published for opposit
Trademark Facts
| Mark | CYLYSE |
|---|---|
| Serial Number | 97770335 |
| Registration Number | 7176194 |
| Status | Registered |
| Filing Date | 2023-01-27 |
| Registration Date | 2023-09-26 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Sysmex Corporation |
| Attorney of Record | Jonathan Brown |
| Prosecution Events | 15 |
| Latest Event | NRCC on 2023-09-26 |
Goods & Services
Chemical reagents for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; In vitro diagnostic preparations and reagents for medical or veterinary purposes; Hemolytic agents for medical or veterinary purposes